High Cost-Sharing Reduces Adherence

High Cost-Sharing Reduces Adherence

RAND researchers found that doubling co-pays reduced patients' adherence to prescribed medicines by 25% to 45% and increased emergency-room visits and hospitalizations.

More On PhRMA — powered by PhRMApedia